abnormal exocrine pancreas morphology, abnormal hypersensitivity reaction, abnormal innate immunity, abnormal interferon level, abnormal interleukin level, abnormal intestinal epithelium morphology, abnormal intestinal mucosa morphology, abnormal intestine physiology, abnormal iron level, abnormal level of surface class II molecules, abnormal lipid level, abnormal myelopoiesis, abnormal neuron physiology, abnormal nitric oxide homeostasis, abnormal osteoblast differentiation, abnormal placental labyrinth vasculature morphology, abnormal protein level, abnormal regulatory T cell physiology, abnormal response to infection, abnormal skeleton physiology, abnormal sleep pattern, abnormal tumor necrosis factor level, abnormal type IV hypersensitivity reaction, abnormal vascular endothelial cell morphology, absent erythroid progenitor cell, cecum inflammation, chronic inflammation, crypts of Lieberkuhn abscesses, decreased T cell proliferation, decreased airway responsiveness, decreased bone mineral content, decreased bone strength, decreased bone trabecula number, decreased circulating interleukin-10 level, decreased circulating iron level, decreased compact bone mass, decreased erythrocyte cell number, decreased hemoglobin content, decreased incidence of tumors by UV induction, decreased interleukin-10 secretion, decreased length of allograft survival, decreased mean systemic arterial blood pressure, decreased physiological sensitivity to xenobiotic, decreased spleen iron level, decreased spleen red pulp amount, decreased susceptibility to induced choroidal neovascularization, decreased susceptibility to parasitic infection, decreased trabecular bone mass, decreased trabecular bone thickness, decreased tumor incidence, decreased vasoconstriction, enhanced wound healing, immune system phenotype, impaired adaptive thermogenesis, impaired exercise endurance, increased CD4-positive, alpha beta T cell number, increased IgG1 level, increased IgG2a level, increased cerebral infarct size, increased circulating interferon-gamma level, increased circulating interleukin-1 alpha level, increased circulating interleukin-1 beta level, increased circulating interleukin-12 level, increased circulating interleukin-17 level, increased circulating interleukin-2 level, increased circulating interleukin-6 level, increased circulating tumor necrosis factor level, increased fatty acids level, increased granulocyte number, increased hepatocyte apoptosis, increased insulin sensitivity, increased interferon-gamma secretion, increased leukotriene level, increased liver triglyceride level, increased myeloid dendritic cell number, increased myocardial infarct size, increased placental labyrinth size, increased plasma cell number, increased sensitivity to induced morbidity/mortality, increased susceptibility to endotoxin shock, increased susceptibility to induced colitis, increased susceptibility to neuronal excitotoxicity, increased susceptibility to parasitic infection, increased susceptibility to type IV hypersensitivity reaction, increased thermal nociceptive threshold, increased thymus weight, increased vasoconstriction, intestinal ulcer, no abnormal phenotype detected, periinsulitis, premature death, slow postnatal weight gain, small intestinal inflammation, spleen hyperplasia